Rezvilutamide for metastatic hormone-sensitive prostate cancer

被引:0
|
作者
Singh, Kirti [1 ]
Mandal, Swarnendu [1 ]
Nayak, Prasant [1 ]
Das, Manoj [1 ]
Tripathy, Sambit [1 ]
机构
[1] All India Inst Med Sci Bhubaneswar, Bhubaneswar 751019, India
来源
LANCET ONCOLOGY | 2022年 / 23卷 / 11期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E490 / E490
页数:1
相关论文
共 50 条
  • [21] Advancements in the treatment of metastatic hormone-sensitive prostate cancer
    Li, Hengping
    Zhang, Mao
    Wang, Xiangrong
    Liu, Yang
    Li, Xuanpeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
    Smith, Matthew R.
    Hussain, Maha
    Saad, Fred
    Fizazi, Karim
    Sternberg, Cora N.
    Crawford, E. David
    Kopyltsov, Evgeny
    Park, Chandler H.
    Alekseev, Boris
    Montesa-Pino, Alvaro
    Ye, Dingwei
    Parnis, Francis
    Cruz, Felipe
    Tammela, Teuvo L. J.
    Suzuki, Hiroyoshi
    Utriainen, Tapio
    Fu, Cheng
    Uemura, Motohide
    Mendez-Vidal, Maria J.
    Maughan, Benjamin L.
    Joensuu, Heikki
    Thiele, Silke
    Li, Rui
    Kuss, Iris
    Tombal, Bertrand
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12): : 1132 - 1142
  • [23] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [24] Treatment options for metastatic hormone-sensitive prostate cancer
    Kostos, Louise
    Murphy, Declan G.
    LANCET ONCOLOGY, 2022, 23 (10): : 1234 - 1235
  • [25] Treatment of primary cancer in metastatic hormone-sensitive prostate cancer
    Lim, Kylie Y. -Y.
    Alberto, Matthew
    Ranasinghe, Weranja
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (04) : 315 - 323
  • [26] Metastatic Hormone-sensitive Prostate Cancer: Patient Selection for Prostate Radiotherapy
    Chakrabarti, Deep
    Parker, Chris C.
    EUROPEAN UROLOGY, 2024, 86 (01) : 18 - 19
  • [28] Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
    Olivier, Timothee
    Tsantoulis, Petros
    Prasad, Vinay
    EUROPEAN UROLOGY, 2023, 83 (06) : 584 - 585
  • [29] Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer
    Ajjai Alva
    Maha Hussain
    Drugs, 2013, 73 : 1517 - 1524
  • [30] Metastatic hormone-sensitive prostate cancer: How should it be treated?
    Lopez-Campos, Fernando
    Gonzalez-San Segundo, Carmen
    Conde-Moreno, Antonio Jose
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (02): : 43 - 49